SCHEMBL7733877

SCHEMBL7733877

CCCCCCCOCCOc1ccc(C(C)=O)cc1

nearest known ligand 0.73

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.70
RARB P10826 4/20 0.65
TP53 P04637 1/20 0.65
TSHR P16473 1/20 0.65
PLA2G4B P0C869 6/20 0.63
PLA2G4A P47712 1/20 0.57
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
THRA P10827 1/20 0.55
THRB P10828 1/20 0.55
NR5A1 Q13285 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738822 1.00 GAA (0.73) GAAL3MBTL1RARBTP53TSHR
SCHEMBL7737425 1.00 GAA (0.73) GAAL3MBTL1RARBTP53TSHR
SCHEMBL7737441 0.94 RARB (0.74) GAAL3MBTL1RARBTP53TSHR
SCHEMBL2354201 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL762326 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL2035476 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL10499017 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL2039972 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL2039230 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR
SCHEMBL15177361 0.92 GAA (0.86) GAAL3MBTL1RARBTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790744-B2 Cyclic peptide antifungal agents and process for preparation thereof ELI LILLY AND COMPANY (US) 2010-09-07 US disclosed
US-6743777-B1 TRISPHENYL ACYL DERIVATIVES OF THE ECHINOCANDIN CLASS; CANDIDA ALBICANS; ANTIFUNGAL AND ANTIPARASITIC; CYCLIC HEXAPEPTIDES HAVING UNIQUE SIDE CHAIN ACYL GROUP ELI LILLY AND COMPANY 2004-06-01 US disclosed